Varenicline decreases nicotine but not alcohol self-administration in genetically selected Marchigian Sardinian alcohol-preferring (msP) rats

Drug and Alcohol Dependence

Volumn 156, Issue , 2015, Pages 126-132

  Scuppa, Giulia ^a   Cippitelli, Andrea ^b   Toll, Lawrence ^b   Ciccocioppo, Roberto ^a   Ubaldi, Massimo ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

^b TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

Author keywords

Addiction; Co abuse; Drug dependence; Ethanol; Tobacco smoking

Indexed keywords

ALCOHOL; NICOTINE; PLACEBO; VARENICLINE; CENTRAL DEPRESSANT AGENT; NICOTINIC AGENT;

ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRINKING BEHAVIOR; DRUG EFFECT; DRUG EFFICACY; DRUG PREFERENCE; DRUG SELF ADMINISTRATION; GENETIC PREDISPOSITION; INSTRUMENTAL CONDITIONING; MALE; MARCHIGIAN SARDINIAN ALCOHOL PREFERRING RAT; NONHUMAN; OUTCOME ASSESSMENT; POST HOC ANALYSIS; PRIORITY JOURNAL; RAT; RAT STRAIN; TOBACCO DEPENDENCE; ANIMAL; ANIMAL BEHAVIOR; DECISION MAKING; DOSE RESPONSE; DRUG EFFECTS; GENETICS;

ALCOHOL DRINKING; ANIMALS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CHOICE BEHAVIOR; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOL; MALE; NICOTINE; NICOTINIC AGONISTS; RATS; SELF ADMINISTRATION; VARENICLINE;

EID: 84946493523     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2015.09.002     Document Type: Article

References (53)

1. Ayanwuyi L.O., Carvajal F., Lerma-Cabrera J.M., Domi E., Bjork K., Ubaldi M., Heilig M., Roberto M., Ciccocioppo R., Cippitelli A. Role of a genetic polymorphism in the corticotropin-releasing factor receptor 1 gene in alcohol drinking and seeking behaviors of marchigian sardinian alcohol-preferring rats. Front. Psychiatry 2013, 4:23.
2. Carnicella S., He D.Y., Yowell Q.V., Glick S.D., Ron D. Noribogaine, but not 18-MC, exhibits similar actions as ibogaine on GDNF expression and ethanol self-administration. Addict. Biol. 2010, 15:424-433.
3. Carroll M.E., Carmona G.G., May S.A. Modifying drug-reinforced behavior by altering the economic conditions of the drug and a nondrug reinforcer. J. Exp. Anal. Behav. 1991, 56:361-376.
4. Chatterjee S., Bartlett S.E. Neuronal nicotinic acetylcholine receptors as pharmacotherapeutic targets for the treatment of alcohol use disorders. CNS Neurol. Disord. Drug Targets 2010, 9:60-76.
5. Chatterjee S., Steensland P., Simms J.A., Holgate J., Coe J.W., Hurst R.S., Shaffer C.L., Lowe J., Rollema H., Bartlett S.E. Partial agonists of the alpha3beta4* neuronal nicotinic acetylcholine receptor reduce ethanol consumption and seeking in rats. Neuropsychopharmacology 2011, 36:603-615.
6. Childs E., Roche D.J., King A.C., de Wit H. Varenicline potentiates alcohol-induced negative subjective responses and offsets impaired eye movements. Alcohol. Clin. Exp. Res. 2012, 36:906-914.
7. Ciccocioppo R., Economidou D., Cippitelli A., Cucculelli M., Ubaldi M., Soverchia L., Lourdusamy A., Massi M. Genetically selected Marchigian Sardinian alcohol-preferring (msP) rats: an animal model to study the neurobiology of alcoholism. Addict. Biol. 2006, 11:339-355.
8. Cippitelli A., Ayanwuyi L.O., Barbier E., Domi E., Lerma-Cabrera J.M., Carvajal F., Scuppa G., Li H., Ubaldi M., Heilig M., Roberto M., Ciccocioppo R. Polymorphism in the corticotropin-releasing factor receptor 1 (CRF1-R) gene plays a role in shaping the high anxious phenotype of Marchigian Sardinian alcohol-preferring (msP) rats. Psychopharmacology 2015, 232:1083-1093.
9. Cippitelli A., Brunori G., Gaiolini K.A., Zaveri N.T., Toll L. Pharmacological stress is required for the anti-alcohol effect of the alpha3beta4* nAChR partial agonist AT-1001. Neuropharmacology 2015, 93C:229-236.
10. Cippitelli A., Wu J., Gaiolini K.A., Mercatelli D., Schoch J., Gorman M., Ramirez A., Ciccocioppo R., Khroyan T.V., Yasuda D., Zaveri N.T., Pascual C., Xie X.S., Toll L. AT-1001: a high-affinity alpha3beta4 nAChR ligand with novel nicotine-suppressive pharmacology. Br. J. Pharmacol. 2015, 172:1834-1845.
11. Dani J.A., Harris R.A. Nicotine addiction and comorbidity with alcohol abuse and mental illness. Nat. Neursci. 2005, 8:1465-1470.
12. de Guglielmo G., Cippitelli A., Somaini L., Gerra G., Li H., Stopponi S., Ubaldi M., Kallupi M., Ciccocioppo R. Pregabalin reduces cocaine self-administration and relapse to cocaine seeking in the rat. Addict. Biol. 2013, 18:644-653.
13. DiFranza J.R., Guerrera M.P. Alcoholism and smoking. J. Stud. Alcohol 1990, 51:130-135.
14. Doyon W.M., Thomas A.M., Ostroumov A., Dong Y., Dani J.A. Potential substrates for nicotine and alcohol interactions: a focus on the mesocorticolimbic dopamine system. Biochem. Pharmacol. 2013, 86:1181-1193.
15. Economidou D., Hansson A.C., Weiss F., Terasmaa A., Sommer W.H., Cippitelli A., Fedeli A., Martin-Fardon R., Massi M., Ciccocioppo R., Heilig M. Dysregulation of nociceptin/orphanin FQ activity in the amygdala is linked to excessive alcohol drinking in the rat. Biol. Psychiatry 2008, 64:211-218.
16. Engle S.E., McIntosh J.M., Drenan R.M. Nicotine and ethanol cooperate to enhance ventral tegmental area AMPA receptor function via alpha6-containing nicotinic receptors. Neuropharmacology 2015, 91:13-22.
17. Enoch M.A., Goldman D. The genetics of alcoholism and alcohol abuse. Curr. Psychiatry Rep. 2001, 3:144-151.
18. Erwin B.L., Slaton R.M. Varenicline in the treatment of alcohol use disorders. Ann. Pharmacother. 2014, 48:1445-1455.
19. Fucito L.M., Toll B.A., Wu R., Romano D.M., Tek E., O'Malley S.S. A preliminary investigation of varenicline for heavy drinking smokers. Psychopharmacology 2011, 215:655-663.
20. Funk D., Marinelli P.W., Le A.D. Biological processes underlying co-use of alcohol and nicotine: neuronal mechanisms, cross-tolerance, and genetic factors. Alcohol Res. Health 2006, 29:186-192.
21. Ginsburg B.C., Lamb R.J. Effects of varenicline on ethanol- and food-maintained responding in a concurrent access procedure. Alcohol. Clin. Exp. Res. 2013, 37:1228-1233.
22. Gordon T.L., Meehan S.M., Schechter M.D. P and NP rats respond differently to the discriminative stimulus effects of nicotine. Pharmacol. Biochem. Behav. 1993, 45:305-308.
23. Gubner N.R., Cunningham C.L., Phillips T.J. Nicotine enhances the locomotor stimulating but not the conditioned rewarding effect of ethanol in DBA/2J mice. Alcohol. Clin. Exp. Res. 2015, 39:64-72.
24. Hansson A.C., Cippitelli A., Sommer W.H., Fedeli A., Bjork K., Soverchia L., Terasmaa A., Massi M., Heilig M., Ciccocioppo R. Variation at the rat Crhr1 locus and sensitivity to relapse into alcohol seeking induced by environmental stress. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:15236-15241.
25. Heilig M., Koob G.F. A key role for corticotropin-releasing factor in alcohol dependence. Trends Neurosci. 2007, 30:399-406.
26. Hendrickson L.M., Guildford M.J., Tapper A.R. Neuronal nicotinic acetylcholine receptors: common molecular substrates of nicotine and alcohol dependence. Front. Psychiatry 2013, 4:29.
27. Hendrickson L.M., Zhao-Shea R., Pang X., Gardner P.D., Tapper A.R. Activation of alpha4* nAChRs is necessary and sufficient for varenicline-induced reduction of alcohol consumption. J. Neurosci. 2010, 30:10169-10176.
28. Hurt R.D., Offord K.P., Croghan I.T., Gomez-Dahl L., Kottke T.E., Morse R.M., Melton L.J. Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort. JAMA 1996, 275:1097-1103.
29. Jorenby D.E., Hays J.T., Rigotti N.A., Azoulay S., Watsky E.J., Williams K.E., Billing C.B., Gong J., Reeves K.R. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA 2006, 296:56-63. Varenicline Phase 3 Study, G.
30. Kamens H.M., Andersen J., Picciotto M.R. Modulation of ethanol consumption by genetic and pharmacological manipulation of nicotinic acetylcholine receptors in mice. Psychopharmacology 2010, 208:613-626.
31. Kuzmin A., Jerlhag E., Liljequist S., Engel J. Effects of subunit selective nACh receptors on operant ethanol self-administration and relapse-like ethanol-drinking behavior. Psychopharmacology 2009, 203:99-108.
32. Larsson A., Edstrom L., Svensson L., Soderpalm B., Engel J.A. Voluntary ethanol intake increases extracellular acetylcholine levels in the ventral tegmental area in the rat. Alcohol Alcohol. 2005, 40:349-358.
33. Le A.D., Li Z., Funk D., Shram M., Li T.K., Shaham Y. Increased vulnerability to nicotine self-administration and relapse in alcohol-naive offspring of rats selectively bred for high alcohol intake. J. Neurosci. 2006, 26:1872-1879.
34. Le A.D., Lo S., Harding S., Juzytsch W., Marinelli P.W., Funk D. Coadministration of intravenous nicotine and oral alcohol in rats. Psychopharmacology 2010, 208:475-486.
35. Lenoir M., Ahmed S.H. Supply of a nondrug substitute reduces escalated heroin consumption. Neuropsychopharmacology 2008, 33:2272-2282.
36. Litten R.Z., Ryan M.L., Fertig J.B., Falk D.E., Johnson B., Dunn K.E., Green A.I., Pettinati H.M., Ciraulo D.A., Sarid-Segal O., Kampman K., Brunette M.F., Strain E.C., Tiouririne N.A., Ransom J., Scott C., Stout R., Group N.S. A double-blind, placebo-controlled trial assessing the efficacy of varenicline tartrate for alcohol dependence. J. Addict. Med. 2013, 7:277-286.
37. Liu L., Hendrickson L.M., Guildford M.J., Zhao-Shea R., Gardner P.D., Tapper A.R. Nicotinic acetylcholine receptors containing the alpha4 subunit modulate alcohol reward. Biol. Psychiatry 2013, 73:738-746.
38. Manzardo A.M., Stein L., Belluzzi J.D. Rats prefer cocaine over nicotine in a two-lever self-administration choice test. Brain Res. 2002, 924:10-19.
39. McKee S.A., Harrison E.L., O'Malley S.S., Krishnan-Sarin S., Shi J., Tetrault J.M., Picciotto M.R., Petrakis I.L., Estevez N., Balchunas E. Varenicline reduces alcohol self-administration in heavy-drinking smokers. Biol. Psychiatry 2009, 66:185-190.
40. Mihalak K.B., Carroll F.I., Luetje C.W. Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors. Mol. Pharmacol. 2006, 70:801-805.
41. Miller N.S., Gold M.S. Comorbid cigarette and alcohol addiction: epidemiology and treatment. J. Addict. Dis. 1998, 17:55-66.
42. Mingione C.J., Heffner J.L., Blom T.J., Anthenelli R.M. Childhood adversity, serotonin transporter (5-HTTLPR) genotype, and risk for cigarette smoking and nicotine dependence in alcohol dependent adults. Drug Alcohol Depend. 2012, 123:201-206.
43. Mitchell J.M., Teague C.H., Kayser A.S., Bartlett S.E., Fields H.L. Varenicline decreases alcohol consumption in heavy-drinking smokers. Psychopharmacology 2012, 223:299-306.
44. Picciotto M.R., Zoli M., Rimondini R., Lena C., Marubio L.M., Pich E.M., Fuxe K., Changeux J.P. Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature 1998, 391:173-177.
45. Plebani J.G., Lynch K.G., Rennert L., Pettinati H.M., O'Brien C.P., Kampman K.M. Results from a pilot clinical trial of varenicline for the treatment of alcohol dependence. Drug Alcohol Depend. 2013, 133:754-758.
46. Randall P.A., Jaramillo A.A., Frisbee S., Besheer J. The role of varenicline on alcohol-primed self-administration and seeking behavior in rats. Psychopharmacology 2015, 14:2443-2454.
47. Rollema H., Chambers L.K., Coe J.W., Glowa J., Hurst R.S., Lebel L.A., Lu Y., Mansbach R.S., Mather R.J., Rovetti C.C., Sands S.B., Schaeffer E., Schulz D.W., Tingley F.D., Williams K.E. Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid. Neuropharmacology 2007, 52:985-994.
48. Rollema H., Coe J.W., Chambers L.K., Hurst R.S., Stahl S.M., Williams K.E. Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation. Trends Pharmacol. Sci. 2007, 28:316-325.. PMID: 17573127.
49. Romberger D.J., Grant K. Alcohol consumption and smoking status: the role of smoking cessation. Biomed. Pharmacother. 2004, 58:77-83.
50. Steensland P., Simms J.A., Holgate J., Richards J.K., Bartlett S.E. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:12518-12523.
51. Tapper A.R., McKinney S.L., Nashmi R., Schwarz J., Deshpande P., Labarca C., Whiteaker P., Marks M.J., Collins A.C., Lester H.A. Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization. Science 2004, 306:1029-1032.
52. Tizabi Y., Copeland R.L., Louis V.A., Taylor R.E. Effects of combined systemic alcohol and central nicotine administration into ventral tegmental area on dopamine release in the nucleus accumbens. Alcohol. Clin. Exp. Res. 2002, 26:394-399.
53. Tyndale R.F. Genetics of alcohol and tobacco use in humans. Ann. Med. 2003, 35:94-121.